MD Neurochir
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
01-07
micro format · 30 days before the deadline
2025
31-12
Financial
Equity above €200,000equity €252,553 ▲45.8%
With a profit in every financial year since 2024, equity grows to €252,553.
27-08
micro format · 27 days late
2024
01-03
Gazette deed
IncorporationStarting capital €3,500 · Appointment: MORELLI Daniele (director) · Founder6 points ▸
Gazette deed
Incorporation
Starting capital €3,500 · Appointment: MORELLI Daniele (director) · Founder6 points ▸
- Incorporation, 27-02-2024
- Founder, MORELLI Daniele
- Capital
- Director appointment, MORELLI Daniele (director (not named in the articles))
- Founding capital, €3,500
- Pre-incorporation commitments, “takeover, tous engagements souscrits par le fondateur pour le compte de la société en formation” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
On 28 February 2024, MD Neurochir was incorporated as a private limited company by one natural person, with a starting capital of €3,500.12 MORELLI Daniele is director of the company, appointed in the act of 01-03-2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3